Key Patent for Platform Technology to Treat or Inhibit HBV and HIV Infections
Indaptus Therapeutics, Inc. (Nasdaq: INDP) ("Indaptus" or the "Company”), today announced that the United States Patent and Trademark Office has issued a notice of allowance for claims related to the Company’s platform technology.
The patent, titled, “Methods of Treatment of Infections Using Bacteria,” (Application No. 16/584,644) provides broad protection for the application of the Company’s platform technology alone and in combination with standards of care for the treatment and inhibition of hepatitis B virus (HBV) and human immunodeficiency virus (HIV) infections.
https://finance.yahoo.com/news/indaptus-therapeutics-receives-notice-allowance-110000625.html
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.